Lenskart's manufacturing scale vs Titan's optometrist model: India's $9.2B eyewear market diverges on strategy

Lenskart posted Rs 2,146.6 crore revenue (+24% YoY) and 19.8% EBITDA margin on a 35-40% cost advantage from in-house manufacturing (4M frames) and 69.2% product margins; Titan Eyewear's income rose to Rs 215 crore but EBIT margin compressed to 5.3-5.7% as it leans on 871 EyeCare stores and 9.3M eye tests to defend its 12% share.

— FiledMon, 20 Jul, 2026, 07:07 IST·First seen Mon, 20 Jul, 2026, 07:06 IST·Source Financial Express · BrandWagon

What happened

Lenskart and Titan Eyewear compare Q2 FY26 strategies in India's $9.2B eyewear market—Lenskart leads on manufacturing cost advantage and fast delivery, Titan on

Key facts

  • Rs 390 listing price
  • Rs 402 issue price
  • -2.23% monthly
  • +0.99% Titan monthly
  • +10.85% Titan yearly
  • 750 million people need vision correction
  • $9.2 billion market
  • Rs 30,000 crore market
  • 12% Titan share
  • 9.3 million eye tests
  • 46% first-time users
  • 203 net new stores
  • 431 cities
  • 871 EyeCare stores
  • 69.2% product margin
  • 35-40% cost advantage
  • 4 million frames manufactured
  • Rs 2,146.6 crore revenue
  • 24% YoY growth
  • Rs 425.8 crore EBITDA
  • 19.8% margin
  • 19.5% H1 margin
  • Rs 215 crore Titan income
  • Rs 199 crore prior
  • Rs 12 crore EBIT
  • Rs 24 crore prior EBIT
  • 5.3-5.7% margin

Why this matters

The diverging strategies—Lenskart's vertically integrated manufacturing vs Titan's service-heavy retail footprint—point to a market where M&A or supply-chain partnerships could reshape competitive positioning as margins bifurcate.

What to watch

  • Titan EBIT margin dropping below 5% in next quarterly report
  • Lenskart announcing new manufacturing capacity or frame-count expansion
  • Titan launching an in-house manufacturing initiative or acquiring a frame maker
  • Regulatory/GST changes affecting eyewear pricing structure
  • Lenskart entering premium/EyeCare-style service centers at scale
  • Track Titan's Q-on-Q EBIT margin trajectory for signs of stabilization vs continued erosion
  • Watch Lenskart's IPO/pre-IPO disclosures for capacity expansion plans beyond 4M frames
  • Monitor Titan EyeCare store additions rate vs same-store sales growth
  • Check for Lenskart moving into eye-test/optometry services to erode Titan's differentiation
  • Watch for private-label entrants (Reliance, Tata other verticals) exploiting the manufacturing-cost gap Lenskart has exposed